Panacur 10% Horse, Cattle & Sheep Wormer (1 Litre)

PANACUR 10% HORSE, CATTLE & SHEEP WORMER - 1 LITRE

Horses
For the treatment and control of adult and immature roundworms of the gastro-intestinal tract in horses and other equines. Panacur effectively treats and controls the following roundworm infections:
Large strongyles (adults and migrating larval stages of Strongylus vulgaris; adults and tissue larval stages of S. edentatus).  Benzimidazole-susceptible adult and immature small strongyles (Cyathostomes).

Panacur is also effective for the treatment and control of encysted mucosal 3rd and 4th stage small strongyle larvae and is also effective against encysted inhibited 3rd stage small strongyle larvae in the mucosa.
Adult and immature Oxyuris spp., Strongyloides spp. and Parascaris equorum.

Panacur also has an ovicidal effect on nematode eggs.

More information:
A 10% suspension of Fenbendazole PhEur as a ready to administer oral anthelmintic for cattle, sheep and horses. 1 ml Panacur 10% Suspension contains 100 mg active ingredient Fenbendazole. Dosage rate for cattle and horses: Administer orally approximately 1 ml Panacur 10% Suspension per 13 kg bodyweight (= 7.5 mg fenbendazole/kg bodyweight). For sheep administer orally 1 ml Panacur 10% Suspension per 20 kg bodyweight (= 5 mg fenbendazole/kg bodyweight).


Legal

Dosage and administration

PANACUR 10% HORSE WORMER
Shake container before use. For oral administration only.
No dietary control is required before or after treatment.
To ensure administration of a correct dose, body weight should be determined as accurately as possible; accuracy of the dosing device should be checked.
Cattle and Horses: Administer orally 1 ml of the product per 13 kg bodyweight. (= 7.5 mg fenbendazole/kg bodyweight)
Practical dosage recommendations:
65 kg 5 ml
135 kg 10 ml
200 kg 15 ml
265 kg 20 ml
335 kg 25 ml
400 kg 30 ml

Above 400 kg, an extra 3.75 ml are required for each additional 50 kg bodyweight.

Horses: Recommended dosage programme.
All horses should be routinely wormed with the single dose regimen every 6-8 weeks.
Treatment of encysted inhibited and encysted mucosal dwelling larvae should be performed in the autumn (ideally late October/November) and again in the Spring (ideally in February). However, for horses who fail to maintain condition or bought-in horses with unknown worming history, the treatment can be given at any time of the year.
Five day course
For the treatment and control of migrating and issue larval stages of large strongyles, encysted mucosal 3rd and 4th stage small strongyle larvae and encysted inhibited 3rd stage small strongyle larvae in the mucosa administer 5 ml of the product per 64 kg bodyweight daily for 5 days (= 7.5 mg fenbendazole/kg bodyweight daily for 5 days).
Single dose treatment
For the treatment and control of encysted mucosal stages of small strongyles administer 3 ml of the product per 10 kg bodyweight (= 30 mg fenbendazole / kg bodyweight).
For the treatment and control of migrating and tissue stages of large strongyles administer 6 ml of the product per 10 kg bodyweight (= 60 mg fenbendazole / kg bodyweight).
For the treatment of diarrhoea cause by Strongyloides westeri in two to three week old sucking foals administer 5 ml of the product per 10kg bodyweight (= 50mg fenbendazole / kg bodyweight).
Do not mix with other products.


 

Contra-indications, warnings, etc

Do not usen Panacur Liquid in horses and other equines intended for human consumption.
Care should be taken to avoid the following practices because they increase the risk of development of resistance and could ultimately result in ineffective therapy:
- Too frequent and repeated use of anthelmintics from the same class, over an extended period of time.
- Underdosing, which may be due to underestimation of body weight, misadministration of the product, or lack of calibration of the dosing device (if any).
Suspected clinical cases of resistance to anthelmintics should be further investigated using appropriate tests (e.g. Faecal Egg Count Reduction Test). Where the results of the test(s) strongly suggest resistance to a particular anthelmintic, an anthelmintic belonging to another pharmacological class and having a different mode of action should be used.
Resistance to benzimidazoles (which include fenbendazole) has been reported in Teladorsagia, Haemonchus, Cooperia and Trichostrongylus species in small ruminants in a number of countries, including the EU. Therefore the use of this product should be based on local (regional, farm) epidemiological information about susceptibility of nematodes and recommendations on how to limit further selection for resistance to anthelmintics.
Resistance to fenbendazole has been reported in cyathostomes in horses. Therefore the use of this product should be based on local (regional, farm) epidemiological information about susceptibility of nematodes and recommendations on how to limit further selection for resistance to anthelmintics.
When incorporating this product into liquid feed, after thoroughly shaking the suspension, measure the required volume of the suspension and add it to approximately 10% of the liquid feed. Thoroughly mix this material and then add the remaining liquid feed and once again mix to produce a homogenous dispersion. Mix the medicated feed thoroughly prior to administration for example by rolling the drum or barrel.
Assess bodyweight as accurately as possible before calculating the dosage. Intensive use or misuse of anthelmintic can give rise to resistance. To reduce this risk, dosing programmes should be discussed with your veterinary surgeon.
Fenbendazole belongs to the benzimidazole (1‑BZ) class of anthelmintics.
Do not mix with other products.

Operator warnings
Direct contact with the skin should be kept to a minimum. Wear suitable protective clothing including impermeable rubber gloves.
Wash hands after use.
For animal treatment only. Keep out of reach and sight of children.